S&P 500   3,370.84 (-0.28%)
DOW   29,239.82 (-0.54%)
QQQ   234.77 (+0.06%)
AAPL   318.99 (-1.83%)
FB   217.38 (+1.49%)
MSFT   186.99 (+0.88%)
GOOGL   1,520.26 (+0.10%)
AMZN   2,162.00 (+1.27%)
CGC   22.40 (+1.22%)
NVDA   294.69 (+1.69%)
BABA   219.80 (+0.08%)
MU   57.79 (-1.21%)
GE   12.80 (-0.31%)
TSLA   849.22 (+6.15%)
AMD   57.16 (+3.34%)
T   38.28 (+0.05%)
ACB   1.65 (+4.43%)
F   8.05 (-0.62%)
NFLX   388.68 (+2.18%)
PRI   135.76 (-0.80%)
BAC   34.26 (-1.69%)
DIS   138.71 (-0.59%)
S&P 500   3,370.84 (-0.28%)
DOW   29,239.82 (-0.54%)
QQQ   234.77 (+0.06%)
AAPL   318.99 (-1.83%)
FB   217.38 (+1.49%)
MSFT   186.99 (+0.88%)
GOOGL   1,520.26 (+0.10%)
AMZN   2,162.00 (+1.27%)
CGC   22.40 (+1.22%)
NVDA   294.69 (+1.69%)
BABA   219.80 (+0.08%)
MU   57.79 (-1.21%)
GE   12.80 (-0.31%)
TSLA   849.22 (+6.15%)
AMD   57.16 (+3.34%)
T   38.28 (+0.05%)
ACB   1.65 (+4.43%)
F   8.05 (-0.62%)
NFLX   388.68 (+2.18%)
PRI   135.76 (-0.80%)
BAC   34.26 (-1.69%)
DIS   138.71 (-0.59%)
S&P 500   3,370.84 (-0.28%)
DOW   29,239.82 (-0.54%)
QQQ   234.77 (+0.06%)
AAPL   318.99 (-1.83%)
FB   217.38 (+1.49%)
MSFT   186.99 (+0.88%)
GOOGL   1,520.26 (+0.10%)
AMZN   2,162.00 (+1.27%)
CGC   22.40 (+1.22%)
NVDA   294.69 (+1.69%)
BABA   219.80 (+0.08%)
MU   57.79 (-1.21%)
GE   12.80 (-0.31%)
TSLA   849.22 (+6.15%)
AMD   57.16 (+3.34%)
T   38.28 (+0.05%)
ACB   1.65 (+4.43%)
F   8.05 (-0.62%)
NFLX   388.68 (+2.18%)
PRI   135.76 (-0.80%)
BAC   34.26 (-1.69%)
DIS   138.71 (-0.59%)
S&P 500   3,370.84 (-0.28%)
DOW   29,239.82 (-0.54%)
QQQ   234.77 (+0.06%)
AAPL   318.99 (-1.83%)
FB   217.38 (+1.49%)
MSFT   186.99 (+0.88%)
GOOGL   1,520.26 (+0.10%)
AMZN   2,162.00 (+1.27%)
CGC   22.40 (+1.22%)
NVDA   294.69 (+1.69%)
BABA   219.80 (+0.08%)
MU   57.79 (-1.21%)
GE   12.80 (-0.31%)
TSLA   849.22 (+6.15%)
AMD   57.16 (+3.34%)
T   38.28 (+0.05%)
ACB   1.65 (+4.43%)
F   8.05 (-0.62%)
NFLX   388.68 (+2.18%)
PRI   135.76 (-0.80%)
BAC   34.26 (-1.69%)
DIS   138.71 (-0.59%)
Log in

Abeona Therapeutics Price Target & Analyst Ratings (NASDAQ:ABEO)

$3.48
+0.31 (+9.76 %)
(As of 02/18/2020 02:39 PM ET)
Today's Range
$3.22
Now: $3.49
$3.75
50-Day Range
$2.17
MA: $2.70
$3.49
52-Week Range
$1.46
Now: $3.49
$8.41
Volume2.83 million shs
Average Volume1.45 million shs
Market Capitalization$178.26 million
P/E RatioN/A
Dividend YieldN/A
Beta2.16

Analyst Ratings

Abeona Therapeutics (NASDAQ:ABEO) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
7 Wall Street analysts have issued ratings and price targets for Abeona Therapeutics in the last 12 months. Their average twelve-month price target is $7.83, suggesting that the stock has a possible upside of 124.77%. The high price target for ABEO is $16.00 and the low price target for ABEO is $4.00. There are currently 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyHoldHoldBuy
Consensus Rating Score: 2.572.402.402.50
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $7.83$8.75$16.00$19.67
Price Target Upside: 124.77% upside156.22% upside555.74% upside697.84% upside

Abeona Therapeutics (NASDAQ:ABEO) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Abeona Therapeutics (NASDAQ:ABEO) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/10/2020Leerink SwannInitiated CoverageBuy$6.00High
2/10/2020Svb LeerinkInitiated CoverageOutperform$6.00High
1/21/2020HC WainwrightInitiated CoverageBuy$11.00High
12/10/2019Cantor FitzgeraldInitiated CoverageHold$4.00High
12/10/2019MizuhoReiterated RatingHold$4.00High
8/15/2019Maxim GroupDowngradeBuy ➝ HoldHigh
8/13/2019Royal Bank of CanadaLower Price TargetOutperform ➝ Positive$16.00High
11/13/2018CitigroupLower Price TargetBuy ➝ Buy$32.00 ➝ $28.00Low
6/27/2018B. RileyInitiated CoverageBuy$26.00Medium
6/5/2018Seaport Global SecuritiesInitiated CoverageBuy$29.00High
5/16/2018SunTrust BanksLower Price TargetBuy ➝ Positive$23.00High
(Data available from 2/18/2018 forward)
This page was last updated on 2/18/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel